Table S2 from Enitociclib, a Selective CDK9 Inhibitor, Induces Complete Regression of MYC+ Lymphoma by Downregulation of RNA Polymerase II Mediated Transcription
- Melanie M. Frigault (17363172)
- Arushi Mithal (17363175)
- Harvey Wong (17363178)
- Beatrix Stelte-Ludwig (17363181)
- Vinay Mandava (17363184)
- Xin Huang (17363187)
- Joseph Birkett (17363190)
- Amy J. Johnson (17363193)
- Raquel Izumi (15046592)
- Ahmed Hamdy (17363196)
Publication date
November 2023
DOIAbstract
Supplementary Table 2 contains the statistical analysis for pSer2 downregulation in SU-DHL-4 and SU-DHL-10 cell lines across CDK9 inhibitor treatments.</p
Add to ORKG